Clinical Trial Enrollment Now Completed for Patients with Wet Macular Degeneration
The physicians of Southeastern Retina Associates are pleased to announce that enrollment is completed for a clinical trial for patients with previously untreated wet age related macular degeneration (AMD). This trial is led by Chattanooga area investigators Dr. Francis Char DeCroos and Dr. Richard I. Breazeale with the goal of treating wet AMD in a more customized, patient centric fashion. The trial is designed to investigate an innovative method of treating wet AMD with fewer treatments and fewer clinical visits, while at the same time obtaining the best possible vision outcomes. This multi-center prospective clinical trial is available at only at a handful of sites across the United States including Chattanooga, Tennessee. The team of scientists responsible for this trial will be actively monitoring participating patients for the next two years. Southeastern Retina Associates maintain an active clinical research program from multiple locations across Eastern Tennessee. These retina specialists are committed to advancing the care of medical and surgical retinal diseases through participation in research. Our team firmly believes that research to improve the standard of care tomorrow allows us to provide the best patient outcomes today.